Center for Scientific Review; Notice of Closed Meetings, 37278 [2015-15945]
Download as PDF
<![CDATA[
37278
Federal Register / Vol. 80, No. 125 / Tuesday, June 30, 2015 / Notices
drive higher risk persons to donate
blood.
Because our study will build off the
routine blood donor procedures in four
large blood banks in Brazil, it may lead
to more informed conversations around
and possible changes in donor
screening, notification and counseling
policies in Latin America. Results of
these three aims may also help to better
integrate blood centers within the
context of broader HIV testing,
counseling and treatment sites in Brazil.
Similarly, in the US little is known
about donor behavior after notification
of testing results by blood centers. The
results from this study can be used to
develop insights and hypotheses
focused on developing improved
strategies for notification and
counseling of HIV-positive (or hepatitis
C or B-positive) donors in the U.S.
This proposed study’s findings will
also yield insights into improved
methods for donor self-selection and
qualification post donation, which will
serve to decrease the frequency of
higher-risk persons acting as donors.
Our findings on improved methods for
Brazilian donor notification and linkage
to health care services may also be
applicable to developed countries,
including the US. Results of the Brazil
Notification Study will identify how to
improve notification and counseling
strategies that increase the number of
HIV-positive donors seeking prompt
medical care. This might ultimately
boost strategies to prevent secondary
HIV transmission and reduce the risk of
transfusion-transmission.
In addition to the traditional route of
scientific dissemination through peer
reviewed scientific publication,
previous REDS and REDS–II study data
were the subject of numerous requested
presentations by Federal and nonFederal agencies, including the FDA
Blood Products Advisory Committee,
the HHS Advisory committee on Blood
Safety and Availability, the AABB
Transfusion-Transmitted Diseases
Committee, and the Americas Blood
Centers (ABC). We anticipate similar
requests for results generated from this
study. Data collected in this proposed
HIV Notification study of donors will be
of practical use to the blood banking
and infectious disease communities in
the US and internationally.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
229.
ESTIMATED ANNUALIZED BURDEN HOURS
ACASI Questionnaire—Informed Consent.
ACASI Questionnaire ............................
Adults ...................
275
1
10/60
46
Adults ...................
275
1
40/60
183
[FR Doc. 2015–15841 Filed 6–29–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Respiratory Sciences.
VerDate Sep<11>2014
17:34 Jun 29, 2015
Jkt 235001
Date: July 6, 2015.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Lawrence E. Boerboom,
Ph.D., Chief, CVRS IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4130, MSC 7814,
Bethesda, MD 20892, (301) 435–8367,
boerboom@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Asthma, Pulmonary Fibrosis and
Inflammation.
Date: July 6–7, 2015.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Bradley Nuss, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC7814, Bethesda, MD 20892, 301–451–
8754, nussb@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Average burden
per response
Estimated total
annual burden
hours requested
Type of
respondent
Dated: June 16, 2015.
Valery Gheen,
NHLBI Project Clearance Liaison, National
Institutes of Health.
Number of
respondents
Number of
responses per
respondent
Form name
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 24, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–15945 Filed 6–29–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\30JNN1.SGM
30JNN1
]]>Agencies
[Federal Register Volume 80, Number 125 (Tuesday, June 30, 2015)]
[Notices]
[Page 37278]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15945]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Respiratory Sciences.
Date: July 6, 2015.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Lawrence E. Boerboom, Ph.D., Chief, CVRS IRG,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4130, MSC 7814, Bethesda, MD 20892, (301) 435-
8367, boerboom@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Asthma, Pulmonary Fibrosis and
Inflammation.
Date: July 6-7, 2015.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Bradley Nuss, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4142, MSC7814, Bethesda, MD 20892, 301-451-
8754, nussb@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: June 24, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-15945 Filed 6-29-15; 8:45 am]
BILLING CODE 4140-01-P
